DHR - Danaher unit Cepheid wins approval of point-of-care hepatitis C test June, 27 2024 06:17 PM Danaher Corporation 2024-06-27 18:17:57 ET More on Danaher Mar Vista - Danaher: Headwinds Are Primarily Cyclical, Growth To Regain Momentum Danaher Corporation: A Good Medium-Term Bet Value Vs. Growth? Danaher Says Why Not Both? Danaher Corporation (DHR) Presents at BofA Securities 2024 Health Care Conference Call Transcript For further details see: Danaher unit Cepheid wins approval of point-of-care hepatitis C test